Work

Osimertinib activity in patients (pts) with leptomeningeal (LM) disease from non-small cell lung cancer (NSCLC): Updated results from BLOOM, a phase I study.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.9002

Authors: James Chih-Hsin Yang, Dong-Wan Kim, Sang-We Kim, Byoung Chul Cho, Jong-Seok Lee, Xin Ye, Xiaolu Yin, Zhenfan Yang, Haiyi Jiang, Myung-Ju Ahn

Institutions: National Taiwan University Hospital, Seoul National University Hospital, Asan Medical Center, Yonsei University, Yonsei University Health System, Yonsei Cancer Hospital, Seoul National University, Seoul National University Bundang Hospital, Samsung Medical Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2527757234

Cites:

Cited by: 95

Related to: 10